GSK seeks Director, Government Affairs, Europe

GSK 5<y Senior Level  Brussel, Brussels Hoofdstedelijk Gewest, Belgium 18 Nov 2017

Job Description

Director, Government Affairs, Europe

30% – GSK’s industry association agenda

  • Establish and drive GSK priorities in the European industry association (EFPIA). This will require internal alignment in terms of the objectives and strategy we would prefer EFPIA to pursue and the formulation of public policy positions; strategic advice and concise briefing for GSK’s senior representatives on the EFPIA General Assembly; Board and its committees; EMC and all working groups; and effective influencing through a broad industry network of counterparts
  • Act as the key coordination point for GSK engagement with EFPIA and for ensuring its activity is understood and supported by internal customers
  • Work with EFPIA staffers on improving association and industry coordination, focus and cohesion in terms of ways of working and clear objectives and deliverables.

40% – Priority markets (UK, France, Spain, Italy, Germany)

  • Drive internal understanding and external advocacy in these markets towards focused pan-regional deliverables in response to key external developments impacting the Pharma business (e.g. joint national collaborations on pricing and purchasing, international reference pricing, national pricing and reimbursement stability agreements alongside Market Access colleagues, multilateral round-tables, Falsified Medicines Directive, Brexit,)
  • Own engagement of and consultation with the government affairs leads and General Managers including through facilitation of the European Government Affairs Strategy Team (EGAST) and, working with the VP-Europe CGA, input to the Pharma European Leadership Team agendas
  • Play a significant part in coordination of GSK-led advocacy in and above country with clear deliverables for the business on strategic regional policy or product priorities (including Trelegy launches)
  • Lead ‘listening and analysis’ and reporting of the potential and current policy agenda and wider external social, economic and political developments of enterprise interest, joining the dots between different markets towards analysis that truly influences short and medium-term business decision-making and performance, especially across the markets of highest revenue
  • Align with wider Global Pharma CGA, Brussels CGA team, and Corporate CGA on policy positioning, listening and analysis, issues management and priority enterprise-wide projects (eg Brexit, influencing EU Bulgarian or future Presidencies) for partial delivery through the relevant markets.
  • Lead on improving internal visibility of regional government affairs activity and specifically the deliverables and impact for the business.

30% – European small and medium-sized markets/clusters

  • Offer pastoral care and leadership as part of a functional approach for market government affairs leads and drive the region’s strategic government affairs objectives across the small and medium-sized markets (previously Area 2), including some of the vaccines agenda but this will be led by the regional Vaccines CGA head)
  • Own and deliver the EGAN/EPAN or equivalent meetings in consultation with LOCs and wider GSK incl. Vaccines, ViiV (for the purposes of alliance markets) and Corporate
  • Act as a source of strategic counsel for and represent the government affairs priorities of these markets in CGA and amongst regional and wider Commercial seniors
  • Support the LOCs and align with One Pharma CGA, Brussels team and Corporate CGA on issues management and priority projects (eg Brexit, pricing) when it comes to delivery through the markets
  • Align with the regional above country market access team to bring government affairs expertise as part of an integrated approach which maximises the prospects of success with customers.


The relatively lean above country CGA structure in Europe combined with the volume of activity and high number of variable market archetypes including dynamic, face-moving internal and external environments requires:

  • Demonstrated very good corporate organisational understanding and commercial acumen
  • Demonstrated strong project and change management skills
  • The combination of strategic government affairs capability and the knowledge and willingness to get involved in tactical delivery
  • Demonstrated good understanding of how communications and government affairs can be woven together in a more complex campaigning approach
  • A natural team orientated attitude and ability to work well and gain the trust of colleagues in the matrix
  • Extensive matrix working in general. The role holder must be highly credible and capable of communicating well with stakeholders including VPs, SVPs and GMs often based in other locations
  • Long-standing exposure to, experience of anticipating and proactive preparation for often complex government affairs and public policy issues and triggers is fundamental.

Accountability, Relationships, Networks and Core Stakeholders

  • Accountable to the VP CGA, Europe
  • Close alignment with regional Communications lead as part of an integrated internal business partnering and external campaigning approach
  • Relationships to be held with the following partners and core stakeholders:
    • SVPs for Europe above-country and LOC General Managers (SVPs/VPs)
    • Senior officials at EFPIA including the Director General and his leadership team
  • Proactive and engaged member of the following networks:
    • Europe CGA lead team (VP chaired)
    • European Government Affairs Strategy Team (incl. the heads of government affairs in priority markets)
  • European Government Affairs and Patient Advocacy Networks.

Preferred qualifications

  • Degree/ Post Degree qualification
  • Highly experienced government affairs and public policy professional with strong business acumen and preferably CGA if not broader experience in a commercial setting, capable of influencing and business partnering at a senior level and across a complex matrix and region of markets
  • Proven track record of developing and implementing impactful government affairs strategies in the private sector preferably at an above country/multilateral level
  • Excellent knowledge of the GSK internal and external operating environment, specifically how it affects prescription-only medicines
  • Highly skilled in managing complex issues (external and internal), identifying areas of control, mobilising the internal response and resolving effectively, especially in a highly regulated environment
  • Values-led leadership approach with an excellent track record in delivering through people and managing performance through stretch assignments, effective delegation and clear planning/tracking/evaluation
  • Exquisite personal judgment, behavioural flexibility and experience of working internationally across multiple and varied cultures, preferably with some experience of other European languages.

Strong understanding and translation of complex public policy subject-matter, similarly complex policy influencing networks which require highly thoughtful solutions to achieve the good outcomes for the business, shareholders and patients. This also requires a first class understanding of the industry and healthcare markets and systems, with experience of having been involved in tackling some of the key questions facing countries today, not least the challenge of supporting and delivering to patients unprecedented medical innovation in the context of public financial austerity.


To lead devising, driving and delivering the government affairs strategic objectives in the region (£~5bn revenue) in support of commercial and wider One Pharma and One GSK IPT priorities, partly as the principal conduit with and day-to-day influence on the industry association (EFPIA) agenda in Europe, mostly by working through a complex matrix of very different market archeotypes in 6 of the 8 global major/priority GSK markets and finally but to a lesser extent in small to medium-sized markets.
30% – GSK’s industry association agenda
40% – Priority markets (UK, France, Spain, Italy, Germany)
30% – European small and medium-sized markets/clusters (covering secondment)


Closing date for applications: 3rd December 2017


800 total views, 2 today Print Job